NCT03927508View on ClinicalTrials.gov

First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 14, 2019

Primary Completion Date

December 19, 2019

Study Completion Date

January 23, 2020

Conditions

Pulmonary Embolism

Interventions

DRUG

r-tPA

Pulse spray and infusion

DEVICE

The Bashir™ Endovascular Catheter

The Bashir™ Endovascular Catheter is a device intended for the localized infusion of therapeutic agents into the pulmonary artery and peripheral vasculature.

Trial Locations (5)

10032

Columbia University Medical Center - Presbyterian - New York, New York

16507

University Pittsburg Medical Center - Hamot, Erie

19140

Temple University Hospital, Philadelphia

32803

Advent Health Orlando, Orlando

46260

St Vincent Hospital and Health Care Center, Inc., Indianapolis

All Listed Sponsors

lead

Thrombolex, Inc.

INDUSTRY

NCT03927508 - First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter